STSS sees explosive jump in premarket trading today. The stock surges to $7.44 – nearly double its previous closing price of $3.74 – marking an impressive rally of close to 100%.
Sharps, a medical service company known for its smart safety syringes, has been gaining attention following a major announcement earlier this year. The company signed a multi-year deal to supply 500 million syringes, with deliveries already underway since the first quarter of 2025. To meet the demand, Sharps has been scaling up production and investing in advanced manufacturing tech.
At the heart of the company’s success is its Provensa product line – smart syringes designed to prevent needlestick injuries and eliminate the risk of needle reuse. These syringes not only improve safety for healthcare professionals and patients but also help cut down on medical waste, addressing concerns raised by the World Health Organization about global syringe shortages and sustainability in healthcare.
While there’s no single piece of news driving this morning’s spike, the surge could reflect growing investor confidence in Sharps’ long term strategy and its ability to secure high-impact contracts. With the healthcare industry placing more emphasis on safety and efficiency, companies like Sharps Technology are well – positioned to thrive.
